MicroPhage

About:

MicroPhage, a diagnostic technology company, develops diagnostic testing for bacterial identification and antibiotic susceptibility.

Website: http://microphage.com

Description:

MicroPhage, Inc., a platform diagnostic technology company, develops medical diagnostics for bacterial identification and antibiotic susceptibility/resistance testing. Its products include methicillin-susceptible Staphylococcus aureus (MSSA)/methicillin-resistant Staphylococcus aureus (MRSA) blood culture tests, MRSA screening tests, and MRSA/MSSA screening tests. The company was founded in 2002 and is based in Longmont, Colorado.

Total Funding Amount:

$14.5M

Headquarters Location:

Longmont, Colorado, United States

Founded Date:

2002-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2011-10-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai